Hematopoietic Stem Cells Transplantation Market- North America accounted for over 35% share in global HSCT market closely followed by Europe

The Hematopoietic Stem Cell Transplantation market was valued at USS 5,540 million in 2019 and expected to grow at a CAGR of 15% during the forecast period from 2020 to 2027 to reach around USD 12,072 million in 2027.

Global Hematopoietic Stem Cell Transplantation Market, 2015 – 2027 (USD Million)

Transplantation of bone marrow, umbilical cord blood or peripheral blood derived multipotent hematopoietic stem cells is called as Hematopoietic stem cell transplantation (HSCT). Hematopoietic stem cell transplantation (HSCT) is mainly used in treatment of patients suffering from blood cancer or bone marrow. Hematopoietic stem cell transplantation (HSCT) is widely used and adopted for treatment of leukemia and multiple myeloma. Hematopoietic stem cell transplantation (HSCT) specifically used for the removal of remains of cancer cells with the aid of high doses of chemo therapy with successive stem cell rescue. Hematopoietic stem cell transplantation (HSCT) can also be used in immune therapy to control growth of cancer cells post transplantations as well as to replace sick or damaged marrow owing to therapy or disease.

Hematopoietic stem cell transplantation (HSCT) can be basically categorized as autologous and allogeneic. However, they can be further classified on the basis of different sources of stem cells for HSC including cord blood, bone marrow and PBSC. The suppose to be treated with HSCT can be vary upon multiple factors ranging from type of disease, type of HSCT to be used to accessibility of appropriate donors.

Get Sample Copy With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/57984

Key Trends in Global Hematopoietic Stem Cell Transplantation Market

Strong Demand for Allogenic Transplantation

Allogeneic hematopoietic stem cell transplantation is performed selectively worldwide. In allogeneic HSCT, the donor-derived stem cells offer alloimmunity that allow graft versus tumor effect to remove residual disease and thus avoid relapse. The risk of transplant related mortality has significantly reduced over time with the introduction of better screening processes, introduction of novel transplant management drugs and incorporation of reduced-intensity conditioned protocols. The use of unmatched unrelated donors and partially matched unrelated donors has expanded the availability of allogeneic transplantation. This is expected to trigger the growth of Hematopoietic Stem Cell Transplantation industry during the forecast period.

Impact of COVID 19 on Global Hematopoietic Stem Cell Transplantation Market

COVID 19 has left an unparalleled impact on growth of global Hematopoietic Stem Cell Transplantation industry. The global Hematopoietic Stem Cell Transplantation has witnessed very severe setback like never before. The demand for Hematopoietic Stem Cell Transplantation is expected to be plunged by almost 20% in 2020, in terms of both volume as well as revenue. However, with the beginning of unlock process across the world and anticipation of COVID 19 vaccine to be launched during first half of 2020 is expected to bring recovery in demand for Hematopoietic Stem Cell Transplantation.

Global Hematopoietic Stem Cell Transplantation Market by Type Insights

Based on its type, the global Hematopoietic Stem Cell Transplantation market can be segmented into Autologous HSCT and Allogeneic HSCT. Although it accounted for major share of the HSCT industry in 2019, Autologous HSCT is a critical and intricate medical practice to be used in the treatment for various malignant and non-malignant disorders. Major factors resulted into higher adoption of autologous HSCT include access to hematopoietic progenitor cell transplant, better supportive care and accessibility of breakthrough drugs that resulted into reduced fatality among patients suffering from malignant and non-malignant blood disorders. Autologous HSCT has been popular choice of treatment for leukemia and bone marrow diseases as against allogeneic HSCT on the account of lower of risk of graft versus host disease.

Global Hematopoietic Stem Cell Transplantation Market by Application Insights

Based on its Applications, the global Hematopoietic Stem Cell Transplantation market can be segmented into Leukemia, Lymphoproliferative Disorders, Solid Tumors and Non-malignant Disorders. In 2019. More than 60 thousand people in U.S. alone were diagnosed with blood cancer (Leukemia). It is estimated that currently there are more than 350 thousand active patients of leukemia in U.S.  Increasing usage of HSCT is one of the major treatments effectively increasing survival rate of patients in the region. This in turn driving the growth of HCST industry in North America as well as across the world. Leukemia, and Lymphoproliferative Disorders are collectively dominating the application market for HSCT and likely to maintain its dominance over the forecast period.

Global Hematopoietic Stem Cell Transplantation Market by Regional Insights

North America accounted for over 35% share in global HSCT market closely followed by Europe. Strong demand for HSCT in North America can be attributed to strong network of healthcare facilities with deep penetration of key players across the region. Moreover, favorable reimbursement policies, higher rate awareness among people, and accessibility to treatment has been resulted into increasing number of patients seeking HSCT treatment in the region. However, Asia Pacific is expected to exhibit fastest CAGR during the forecast period.

Global Hematopoietic Stem Cell Transplantation Market Competitive Landscape

Key players operating in the field of manufacturing Hematopoietic Stem Cell Transplantation including but not limited to Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories, Thermo Fisher Scientific, Inc., CellGenixTechnologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group, Pluristem Therapeutics Inc. TiGenix N.V., Takara Bio and Stempuetics Research Pvt. Ltd. Global Hematopoietic Stem Cell Transplantation market is moderatelt concentrated with large number of players.

Market Segmentation

Global Hematopoietic Stem Cell Transplantation Market by Type, 2015 – 2027

·       Autologous HSCT

·       Allogeneic HAST

Global Hematopoietic Stem Cell Transplantation Market by Application, 2015 – 2027

·       Leukemia

·       Lymphoproliferative Disorders

·       Solid Tumors

·       Non-malignant Disorders

Global Hematopoietic Stem Cell Transplantation Market by Region, 2015 – 2027

·       North America

·       Europe

·       Asia Pacific

·       Latin America

·       Middle East and Africa

Global Hematopoietic Stem Cell Transplantation Market: Key Players

·       Escape Therapeutics

·       Kite Pharma Inc.

·       PromoCell GmbH

·       ScienCell Research Laboratories

·       Thermo Fisher Scientific, Inc.

·       CellGenixTechnologie Transfer GmbH

·       Cesca Therapeutics Inc.

·       R&D Systems

·       Genlantis

·       Lonza Group

·       Pluristem Therapeutics Inc

·       TiGenix N.V.

·       Takara Bio

·       Stempuetics Research Pvt. Ltd.

.       Others

Get Sample Copy With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/57984

ToC

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary

2.1. Market Snapshot: Global Hematopoietic Stem Cell Transplantation Market
2.2. Global Hematopoietic Stem Cell Transplantation Market, by Product, 2019 (US$ Bn)
2.3. Global Hematopoietic Stem Cell Transplantation Market, by Application, 2019 (US$ Bn)
2.4. Global Hematopoietic Stem Cell Transplantation Market, by Technology, 2019 (US$ Bn)
2.5. Global Hematopoietic Stem Cell Transplantation Market, by End-user, 2019 (US$ Bn)
2.6. Global Hematopoietic Stem Cell Transplantation Market, by Geography, 2019 (US$ Bn)

3. Market Dynamics

3.1. Introduction
3.1.1. Global Hematopoietic Stem Cell Transplantation Market Value, 2015-2027, (US$ Bn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2019
3.4. Market Positioning of Key Players, 2019
3.4.1. Major Strategies Adopted by Key Players

4. Global Hematopoietic Stem Cell Transplantation Market, by Product, 2015-2027 (US$ Bn)

4.1. Overview
4.2. Autologous HSCT
4.3. Allogeneic HAST

5. Global Hematopoietic Stem Cell Transplantation Market, by End-user, 2015-2027 (US$ Bn)

5.1. Overview
5.2. Leukemia
5.3. Lymphoproliferative Disorders
5.4. Solid Tumors
5.5. Non-malignant Disorders
5.6. Others

6. North America Hematopoietic Stem Cell Transplantation Market Analysis, 2015-2027 (US$ Bn)

6.1. Overview
6.1.1. North America Hematopoietic Stem Cell Transplantation Market Value and Growth, 2015-2027, (US$ Bn)
6.2. North America Hematopoietic Stem Cell Transplantation Market Value, By Product, 2015-2027 (US$ Bn)
6.2.1. Market Analysis
6.3. North America Hematopoietic Stem Cell Transplantation Market Value, By Application, 2015-2027 (US$ Bn)
6.3.1. Market Analysis
6.4. North America Hematopoietic Stem Cell Transplantation Market Value, By Technology, 2015-2027 (US$ Bn)
6.4.1. Market Analysis
6.5. North America Hematopoietic Stem Cell Transplantation Market Value, By End-user, 2015-2027 (US$ Bn)
6.5.1. Market Analysis
6.6. North America Hematopoietic Stem Cell Transplantation Market Value, By Region/Country, 2015-2027 (US$ Bn)
6.6.1. Market Analysis
6.6.2. U.S.
6.6.3. Rest of North America

7. Europe Hematopoietic Stem Cell Transplantation Market Analysis, 2015-2027 (US$ Bn)

8. Asia Pacific Hematopoietic Stem Cell Transplantation Market Analysis, 2015-2027 (US$ Bn)

9. Rest of the World Hematopoietic Stem Cell Transplantation Market Analysis, 2015-2027 (US$ Bn)

10. Company Profiles

10.1. Escape Therapeutics
10.2. Kite Pharma Inc.
10.3. PromoCell GmbH.
10.4. ScienCell Research Laboratories
10.5. Thermo Fisher Scientific, Inc.
10.6. CellGenixTechnologie Transfer GmbH
10.7. Cesca Therapeutics Inc.
10.8. R&D Systems
10.9. Genlantis
10.10. Lonza Group
10.11. Pluristem Therapeutics Inc.
10.12. TiGenix N.V.
10.13. Takara Bio

……………

Get Sample Copy With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/57984

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations,
governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance
with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-800-361-8290
E- mail: sales@credenceresearch.com

Tags: Allogeneic HAST, Non-malignant Disorders, Solid Tumors, Lymphoproliferative Disorders, Autologous HSCT, Hematopoietic Stem Cell Transplantation market, leukemia See Campaign: https://www.credenceresearch.com/report/hematopoietic-stem-cells-transplantation-market
Contact Information:
About Us Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Media Contact Name: Chris Smith Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US (US/CANADA) Ph.: +1-800-361-8290 E- mail:
sales@credenceresearch.com

Tags:
, Reportedtimes, IPS, Extended Distribution, iCN Internal Distribution, Research Newswire, English